AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

9.560

-0.160-1.65%

Volume:25.68K

Turnover:247.58K

Market Cap:479.92M

PE:14.85

High:9.830

Open:9.750

Low:9.520

Close:9.720

52wk High:13.933

52wk Low:9.310

Shares:50.20M

Float Shares:41.32M

Volume Ratio:0.45

T/O Rate:0.06%

Dividend:0.05

Dividend Rate:0.52%

EPS(TTM):0.644

EPS(LYR):0.718

ROE:13.96%

ROA:10.62%

PB:1.93

PE(LYR):13.31

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CLINUVEL PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4909

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":9.56,"timestamp":1774322221016,"preClose":9.72,"halted":0,"volume":25675,"delay":0,"changeRate":-0.01646090534979425,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50200740,"eps":0.643659,"marketStatus":"Trading","change":-0.16,"latestTime":"03-24 14:17:16 AEDT","open":9.75,"high":9.83,"low":9.52,"amount":247583,"amplitude":0.031893,"askPrice":9.58,"askSize":212,"bidPrice":9.56,"bidSize":41,"shortable":3,"etf":0,"ttmEps":0.643659,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774328400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":9.72,"dividendRate":0.00523,"openAndCloseTimeList":[[1774306800000,1774328400000]],"volumeRatio":0.447982,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUV.AU","preClose":9.72,"auctionPrice":9.75,"auctionVolume":1570,"auctionTime":1774306750427,"referenceTime":1774258203088,"auction":1,"marketStatus":"盘前竞价","timestamp":1774306750427}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"10.62%","roe":"13.96%","lyrEps":0.717999,"volumeRatio":0.447982,"shares":50200740,"dividePrice":0.05,"high":9.83,"amplitude":0.031893,"preClose":9.72,"low":9.52,"week52Low":9.31,"pbRate":"1.93","psRate":"4.98","week52High":13.933,"institutionHeld":0,"latestPrice":9.56,"committee":-0.675889,"eps":0.643659,"divideRate":0.00523,"volume":25675,"delay":0,"ttmEps":0.643659,"open":9.75,"prevYearClose":12.46,"prevWeekClose":9.64,"prevMonthClose":10.01,"prevQuarterClose":12.46,"fiveDayClose":9.75,"twentyDayClose":11.22,"sixtyDayClose":12.78,"dividendPayoutRate":0.06921842705277628,"dividendFrequency":"A","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.0025824359172833843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4909"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.1671},{"period":"3month","weight":-0.2591},{"period":"6month","weight":-0.1496},{"period":"1year","weight":-0.1793},{"period":"ytd","weight":-0.2199}],"compareEarnings":[{"period":"1week","weight":-0.0369},{"period":"1month","weight":-0.0767},{"period":"3month","weight":-0.0549},{"period":"6month","weight":0.0071},{"period":"1year","weight":0.071},{"period":"ytd","weight":-0.0568}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.36,"avgChangeRate":-0.039665},{"month":2,"riseRate":0.538462,"avgChangeRate":0.006788},{"month":3,"riseRate":0.52,"avgChangeRate":0.012936},{"month":4,"riseRate":0.52,"avgChangeRate":0.049433},{"month":5,"riseRate":0.24,"avgChangeRate":-0.052146},{"month":6,"riseRate":0.6,"avgChangeRate":0.068032},{"month":7,"riseRate":0.6,"avgChangeRate":0.058534},{"month":8,"riseRate":0.48,"avgChangeRate":-0.004565},{"month":9,"riseRate":0.52,"avgChangeRate":0.020713},{"month":10,"riseRate":0.44,"avgChangeRate":0.036647},{"month":11,"riseRate":0.52,"avgChangeRate":0.025676},{"month":12,"riseRate":0.56,"avgChangeRate":0.063246}],"exchange":"ASX","name":"CLINUVEL PHARMACEUTICALS LTD","nameEN":"CLINUVEL PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":null}}